Jeanine Roodhart

Associate Professor - medical

Strategic program(s):

Contact

jroodha2@umcutrecht.nl

Pure profile

Research groups

Translational oncology

Research aim

To develop, test, and implement novel therapeutic and diagnostic strategies to combat cancer by integrating fundamental and clinical research.

Go to group

Recent publications

All publications

Harnessing the Potential of Real-World Evidence in the Treatment of Colorectal Cancer Sietske C M W van Nassau, Guus M Bol, Frederieke H van der Baan, Jeanine M L Roodhart, Geraldine R Vink, Cornelis J A Punt, Anne M May, Miriam Koopman, Jeroen W G Derksen
Current treatment options in oncology, 2024, vol. 25, p.405-426

Trastuzumab deruxtecan in HER2-positive metastatic colorectal cancer Jeanine M.L. Roodhart, Miriam Koopman
The Lancet Oncology, 2024, vol. 25, p.1104-1105

Survival and patient-reported outcomes of real-world high-risk stage II and stage III colon cancer patients after reduction of adjuvant CAPOX duration from 6 to 3 months Ingrid A. Franken, Frederieke H. van der Baan, Geraldine R. Vink, Anne M. May, Wilhelmina M.U. van Grevenstein, Miriam Koopman, Jeanine M.L. Roodhart
European Journal of Cancer, 2024, vol. 208

DNA damage induces p53-independent apoptosis through ribosome stalling Nicolaas J Boon, Rafaela A Oliveira, Pierré-René Körner, Adva Kochavi, Sander Mertens, Yuval Malka, Rhianne Voogd, Suzanne E M van der Horst, Maarten A Huismans, Lidwien P Smabers, Jonne M Draper, Lodewyk F A Wessels, Peter Haahr, Jeanine M L Roodhart, Ton N M Schumacher, Hugo J Snippert, Reuven Agami, Thijn R Brummelkamp
Science, 2024, vol. 384, p.785-792

Efficacy-effectiveness analysis on survival in a population-based real-world study of BRAF-mutated metastatic colorectal cancer patients treated with encorafenib-cetuximab Koen Zwart, Sietske C M W van Nassau, Frederieke H van der Baan, Miriam Koopman, Petur Snaebjornsson, Anna J van Gestel, Geraldine R Vink, Jeanine M L Roodhart
British Journal of Cancer, 2024, vol. 131, p.110-116

Extrahepatic perfusion and incomplete hepatic perfusion after hepatic arterial infusion pump implantation Wills F. Filipe, Florian E. Buisman, Stijn Franssen, Myrtle F. Krul, Dirk J. Grunhagen, Roel J. Bennink, Karen Bolhuis, Rutger C.G. Bruijnen, Tineke E. Buffart, Mark C. Burgmans, Otto M. van Delden, Pascal G. Doornebosch, Paul D. Gobardhan, Laura Graven, Jan Willem B. de Groot, Cecile Grootscholten, Jeroen Hagendoorn, Paul Harmsen, Marjolein Y.V. Homs, Elizabeth G. Klompenhouwer, Niels F.M. Kok, Marnix G.E.H. Lam, Olaf J.L. Loosveld, Mark A.J. Meier, J. Sven D. Mieog, Ad H.J. Oostdijk, Loubna Outmani, Gijs A. Patijn, Stefan Pool, Daphne D.D. Rietbergen, Jeanine M.L. Roodhart, Frank M. Speetjens, Rutger Jan Swijnenburg, Michelle W.J. Versleijen, Cornelis Verhoef, Koert, F.D. kuhlmann, Adriaan Moelker, Bas Groot Koerkamp, Florian Buismanz Buisman, Bas Groot Koerkamp, Dirk J. Grunhagen, Pascal G. Doornesbosch, Karen Boluis, Koert, F.D. kuhlmann, Jroen Hagendoorn, Rutger Jan Swijnenburg, Inne H.M. Borel Rinkes, Andrea Cercek, Nancy E. Kemeny, T. Peter Kingham,
HPB, 2024, vol. 26, p.919-927

External positions

board member on behalf of UMC Utrecht, Foundation Hubrecht Organoid Technology (HUB)